학술논문

Olokizumab Improves Patient Reported Outcomes in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate: Results from the Double-Blind, Randomized Controlled Phase III Study
Document Type
Journal
Source
ARTHRITIS & RHEUMATOLOGY; OCT 2020, 72 3p. Supplement: 10
Subject
Language
English
ISSN
23265205